Rebecca Bolce

642 total citations
57 papers, 432 citations indexed

About

Rebecca Bolce is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Rebecca Bolce has authored 57 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Rheumatology, 35 papers in Immunology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Rebecca Bolce's work include Rheumatoid Arthritis Research and Therapies (43 papers), Spondyloarthritis Studies and Treatments (37 papers) and Psoriasis: Treatment and Pathogenesis (33 papers). Rebecca Bolce is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (43 papers), Spondyloarthritis Studies and Treatments (37 papers) and Psoriasis: Treatment and Pathogenesis (33 papers). Rebecca Bolce collaborates with scholars based in United States, Germany and Canada. Rebecca Bolce's co-authors include Saedís Saevarsdóttir, Ronald van Vollenhoven, Karen Hambardzumyan, Eric H. Sasso, Theresa Hunter, Kristina Forslind, Jessica A. Walsh, David Sandoval, Ingemar F. Petersson and David Chernoff and has published in prestigious journals such as PLoS ONE, Annals of the Rheumatic Diseases and Journal of the American Academy of Dermatology.

In The Last Decade

Rebecca Bolce

54 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rebecca Bolce United States 12 377 188 107 64 37 57 432
Е. П. Иливанова Russia 6 356 0.9× 186 1.0× 167 1.6× 51 0.8× 79 2.1× 21 448
Karen I. Maijer Netherlands 11 251 0.7× 107 0.6× 65 0.6× 27 0.4× 27 0.7× 13 396
S Wassenberg Germany 6 290 0.8× 105 0.6× 126 1.2× 39 0.6× 36 1.0× 8 408
Sibylle Haemmerle Switzerland 9 419 1.1× 486 2.6× 141 1.3× 137 2.1× 93 2.5× 25 716
Attila Hamar Hungary 9 178 0.5× 70 0.4× 48 0.4× 44 0.7× 26 0.7× 19 272
Elena Aurrecoechea Spain 11 200 0.5× 100 0.5× 53 0.5× 26 0.4× 63 1.7× 28 308
Miriam Teoli Italy 11 157 0.4× 244 1.3× 91 0.9× 36 0.6× 16 0.4× 22 384
Nicolai Leuchten Germany 7 276 0.7× 167 0.9× 31 0.3× 57 0.9× 23 0.6× 20 361
Melinda Kedves Hungary 5 172 0.5× 85 0.5× 59 0.6× 36 0.6× 31 0.8× 6 238
Sirel Gurbuz United States 4 272 0.7× 62 0.3× 131 1.2× 32 0.5× 87 2.4× 8 352

Countries citing papers authored by Rebecca Bolce

Since Specialization
Citations

This map shows the geographic impact of Rebecca Bolce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Bolce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Bolce more than expected).

Fields of papers citing papers by Rebecca Bolce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca Bolce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Bolce. The network helps show where Rebecca Bolce may publish in the future.

Co-authorship network of co-authors of Rebecca Bolce

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca Bolce. A scholar is included among the top collaborators of Rebecca Bolce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca Bolce. Rebecca Bolce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McGonagle, Dennis, Arthur Kavanaugh, Iain B. McInnes, et al.. (2024). Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritis. Lara D. Veeken. 63(11). 3115–3123. 2 indexed citations
2.
Ramiro, Sofía, Cédric Lukas, Louis Bessette, et al.. (2024). Early clinical response associates with long-term outcomes with ixekizumab in radiographic axial spondyloarthritis. RMD Open. 10(3). e004429–e004429.
3.
Kirkham, Bruce, Alexander Egeberg, Frank Behrens, et al.. (2023). A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis. Rheumatology and Therapy. 10(5). 1127–1146. 5 indexed citations
4.
Maksymowych, Walter P., Rebecca Bolce, Gaia Gallo, et al.. (2022). Ixekizumab in radiographic axial spondyloarthritis with and without elevated C-reactive protein or positive magnetic resonance imaging. Lara D. Veeken. 61(11). 4324–4334. 10 indexed citations
5.
Coates, Laura C., Josef S Smolen, Philip J. Mease, et al.. (2022). Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritis. RMD Open. 8(2). e002457–e002457. 4 indexed citations
6.
Landewé, Robert, Denis Poddubnyy, Proton Rahman, et al.. (2022). Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study. Annals of the Rheumatic Diseases. 82(2). 212–216. 2 indexed citations
7.
8.
Deodhar, Atul, Philip J. Mease, Proton Rahman, et al.. (2021). Ixekizumab improves spinal pain, function, fatigue, stiffness, and sleep in radiographic axial Spondyloarthritis: COAST-V/W 52-week results. BMC Rheumatology. 5(1). 35–35. 9 indexed citations
9.
10.
Kiltz, Uta, Désirée van der Heijde, Filip Van den Bosch, et al.. (2020). Ixekizumab Improves Functioning and Health in the Treatment of Radiographic Axial Spondyloarthritis: Week 52 Results from 2 Pivotal Studies. The Journal of Rheumatology. 48(2). 188–197. 6 indexed citations
11.
Eastman, Peter, Ferhan Qureshi, Eric H. Sasso, et al.. (2020). Correlation of serum protein biomarkers with disease activity in psoriatic arthritis. Expert Review of Clinical Immunology. 16(3). 335–341. 10 indexed citations
12.
13.
14.
Markusse, I.M., Linda Dirven, Marianne van den Broek, et al.. (2014). A Multibiomarker Disease Activity Score for Rheumatoid Arthritis Predicts Radiographic Joint Damage in the BeSt Study. The Journal of Rheumatology. 41(11). 2114–2119. 32 indexed citations
15.
Fleischmann, Roy, John A. Goldman, Marjatta Leirisalo‐Repo, et al.. (2014). Infliximab efficacy in rheumatoid arthritis after an inadequate response to etanercept or adalimumab: results of a target-driven active switch study. Current Medical Research and Opinion. 30(11). 2139–2149. 12 indexed citations
16.
Rosenberg, Alexander F., Yahui Grace Chiu, Rebecca Bolce, et al.. (2014). Divergent Gene Activation in Peripheral Blood and Tissues of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis following Infliximab Therapy. PLoS ONE. 9(10). e110657–e110657. 14 indexed citations
17.
Hanami, Kentaro, Shintaro Hirata, H Tasaka, et al.. (2013). FRI0066 Behavior of the multi-biomarker disease activity (vectra da algorithm) score and components in patients with rheumatoid arthritis treated with tocilizumab. Annals of the Rheumatic Diseases. 72. A391–A391. 2 indexed citations
18.
19.
20.
Baraliakos, Xenofon, F. Heldmann, D. van der Heijde, et al.. (2010). RADIOGRAPHIC FINDINGS AFTER 5 YEARS OF INFLIXIMAB TREATMENT IN PATIENTS WITH ANKYLOSING SPONDYLITIS. Clinical and Experimental Rheumatology. 28(4). 633–633. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Е. П. Иливанова Breakdown of academic impact, for papers by Karen I. Maijer Breakdown of academic impact, for papers by S Wassenberg Breakdown of academic impact, for papers by Sibylle Haemmerle Breakdown of academic impact, for papers by Attila Hamar Breakdown of academic impact, for papers by Elena Aurrecoechea Breakdown of academic impact, for papers by Miriam Teoli Breakdown of academic impact, for papers by Nicolai Leuchten Breakdown of academic impact, for papers by Melinda Kedves Breakdown of academic impact, for papers by Sirel Gurbuz
Rankless by CCL
2026